CSI Market
Sign In | Register

Virpax Pharmaceuticals Inc (VRPX) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access VRPX Annual Balance Sheets →
Quarterly balance sheet trends provide context on Virpax Pharmaceuticals Inc's liquidity, leverage, and long-term financial structure.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Dec 31 2024)
(Sep 30 2024) (Jun 30 2024) (Mar 31 2024) (Dec 31 2023)
Assets
Cash & cash equivalent1.51
Cash & Short-term Investments1.00
Prepaid Expense And Other Assets Current0.04
Total Current Assets1.56
Tax Assets, Noncurrent0.00
Other Assets, Noncurrent0.00
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents-
Total Assets1.56
Liabilities
Accounts Payable and Accrued Liabilities, Current LI2.47
Accrued Liabilities, Current0.00
Estimated Litigation Liability, Current0.00
Other Liabilities, Current0.00
Total Current Liabilities2.47
Total Long-term Debt0.00
Accrued Income Taxes, Noncurrent0.00
Total Liabilities2.47
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock70.70
Retained Earnings / Accumulated Deficit-71.61
Other Equity0.00
Common Stockholder's Equity-0.91
Total Stockholder's Equity-0.91
Liabilities & Stockholder's Equity1.56
4 historic quarters locked

Sign in to unlock the full Virpax Pharmaceuticals Inc balance sheet history.

Sign In Create Free Account

About Virpax Pharmaceuticals Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-Q (Period: 20240930)
  • Filed with the SEC: November 14, 2024
  • Source: e6114_10q.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001731122-24-001812

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License